Launch of Generic Advair

Released: 02/06/2019  

By: Heidi Dufrene, PharmD

The generic equivalent of Advair (fluticasone/salmeterol) was recently approved by the FDA and is expected to be available later this month. Advair is manufactured by GlaxoSmithKline and is FDA-approved for the treatment of asthma and COPD.

Generic prescription drugs approved by the FDA have the same high quality and strength as brand name drugs. Generic prescription drug manufacturing and packaging sites must pass the same quality standards as those of brand name drugs.

If you have any questions or if we may assist you with your pharmacy needs, please contact us at 800-553-1783 or at